Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase Agreement Mar 28, 2024 8:11am EDT
Molecular Templates to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference Feb 08, 2024 5:55pm EST
Molecular Templates, Inc. Reports Third Quarter 2023 Financial Results and Business Update Nov 13, 2023 4:11pm EST
Molecular Templates Announces First Patient Dosed in Phase 1 Trial Evaluating MT-8421, a Novel Engineered Toxin Body Targeting CTLA-4, in Advanced Solid Tumors Nov 02, 2023 4:11pm EDT
Molecular Templates Announces the Appointment of Dr. Maurizio Voi to the Role of Chief Medical Officer Sep 28, 2023 4:11pm EDT
Molecular Templates, Inc. Reports Second Quarter 2023 Financial Results and Business Update Aug 10, 2023 8:08am EDT